16 June 2022 - Landsbankinn
As stated in Alvotech’s announcement to mark the occasion, the company is focused solely on the development and manufacture of biosimilar medicines for patients which can reduce the cost of health services worldwide.
Another milestone is scheduled for 23 June with the dual listing of Alvotech on Nasdaq First North in Iceland.
Landsbankinn Corporate Finance, Arion Bank and Arctica Finance were among Alvotech’s advisors during the share capital increase preceding listing.
We congratulate the shareholders and employees of Alvotech on listing.
You may also be interested in
19 Oct. 2026
The educational event Stocks with Landsbankinn - from initial impression to investment was held to a full house at Landsbankinn’s headquarters in Reykjastræti on 15 October.
14 Oct. 2026
Landsbankinn wishes to draw customers’ attention to an investigation by the Reykjavík Metropolitan Police, which revealed that over 300 young people have used an iPhone VPN profile called “Island Surge VPN”.
2 Oct. 2026
Styrkás hf. has signed an agreement to acquire all shares in Malbikstöðin ehf. and the company’s sites at Esjumelar. Landsbankinn Corporate Finance acted as advisor to Styrkás in the transaction.
29 Sept. 2026
Each year we award community grants from Landsbankinn’s Community Fund in the total amount of ISK 20 million.
10 Sept. 2026
University students Salvador Di Marzio Láruson and Oliwia Slodowska are the recipients of grants from Landsbankinn’s Hvatasjóður fund for undergraduate studies at Reykjavík University (RU) 2027-2028.